ESC 365 - RAS-inhibitors and COVID-19 risk.

HFA Premium Access

RAS-inhibitors and COVID-19 risk.

Session: COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice

Topic: Chronic Heart Failure

Speaker: Professor L. Lund (Stockholm, SE)

Event: Heart Failure 2021

Congress Presentation

Add to my library

About the speaker

Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

70 presentations

11 followers

3 more presentations in this session

COVID-19 related heart failure: from systemic infection to cardiac inflammation.

Speaker: Professor M. Metra (Milan, IT)

COVID-19 in patients with chronic heart failure: management and prognosis.

Speaker: Professor Y. Zhang (Beijing, CN)

COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice - discussion.

Access the full session

COVID-19 and cardiorespiratory failure, from pathophysiology to clinical practice

Speakers: Professor L. Lund, Professor M. Metra, Professor Y. Zhang

About the event

Heart Failure 2021

29 June - 1 July 2021

Sessions Presentations

Congress

ESC 365 is supported by

novartis

Explore sponsored resources